Clostridium Difficil-Associated Diarrhea (CDAD) and Proton Pump Inhibitor Therapy: CAG Position Statement

Clostridium Difficil-Associated Diarrhea (CDAD) and Proton Pump Inhibitor Therapy: CAG Position Statement

Saved in:

Bibliographic Details
Main Author:	P Sinclair
Format:	Article
Language:	English
Published:	Wiley 2005-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2005/830275
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nature’s Therapy for Recurrent Clostridium Difficile Diarrhea
by: Thomas Louie, et al.
Published: (2008-01-01)

Canadian Association of Gastroenterology Position Statement: Hip Fracture and Proton Pump Inhibitor Therapy – a 2013 Update
by: Paul Moayyedi, et al.
Published: (2013-01-01)

Clostridium Difficile-Associated Diarrhea in 200 Canadian Children
by: Véronique Morinville, et al.
Published: (2005-01-01)

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea
by: Thomas Louie, et al.
Published: (2015-12-01)

The Value of Repeat Clostridium difficile Toxin Testing during and after an Outbreak of C difficile-Associated Diarrhea
by: Joseph Dylewski
Published: (2011-01-01)

Association between NSAIDs and Clostridium difficile-Associated Diarrhea: A Systematic Review and Meta-Analysis
by: Nitipong Permpalung, et al.
Published: (2016-01-01)

Deprescribing proton pump inhibitors
by: Kim Jun Kevin Teh, et al.
Published: (2023-08-01)

Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01)

Drug risk Factors Associated with a Sustained Outbreak of Clostridium difficile Diarrhea in a Teaching Hospital
by: Swapan K Nath, et al.
Published: (1994-01-01)

Comparison of Culture, Cytotoxin Assay and Two Eia Tests with Clinical Diagnosis of Clostridium difficile-Associated Diarrhea
by: Marilyn Binning, et al.
Published: (1994-01-01)

Clostridium difficile Outbreaks
by: Paul Bayardelle
Published: (2007-01-01)

Proton Pump Inhibitors: How Appropriate?
by: Daniel C Sadowski
Published: (2000-01-01)

Proton pump inhibitor leaflets: Is there information on deprescribing?
by: Marcus Vinícius Lopes Campos, et al.
Published: (2025-01-01)

Empyema Caused by Clostridium difficile
by: Darren A Hudson, et al.
Published: (1999-01-01)

Esophageal pH Testing in Patients Refractory to Proton Pump Inhibitor Therapy
by: Barbara A MacKalski, et al.
Published: (2008-01-01)

<i>Clostridium difficile</i>-associated disease
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01)

Assessment of Severity of Clostridium difficile Infection
by: Subrata Ghosh
Published: (2011-01-01)

Yersinia Infection with Clostridium Difficile Colitis
by: M.J. Fishman, et al.
Published: (1989-01-01)

Blowhole Colostomy for Clostridium difficile-Associated Toxic Megacolon
by: Jeroen Kerstens, et al.
Published: (2016-01-01)

Validation of a Short Questionnaire in English and French for Use in Patients with Persistent Upper Gastrointestinal Symptoms Despite Proton Pump Inhibitor Therapy: The Pass (Proton Pump Inhibitor Acid Suppression Symptom) Test
by: David Armstrong, et al.
Published: (2005-01-01)

Proton Pump Inhibitor Omeprazole Alters the Spiking Characteristics of Proteinoids
by: Panagiotis Mougkogiannis, et al.
Published: (2025-01-01)

Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences
by: Gloria Ortiz-Guerrero, et al.
Published: (2018-01-01)

Proton Pump Inhibitors in the Treatment of Acute Gastroesophageal Reflux Disease
by: Lawrence J Worobetz
Published: (1993-01-01)

Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland
by: Anke van Engen, et al.
Published: (2015-05-01)

Clostridium difficile: An Important Opportunistic Pathogen in Healthcare-Associated Infections
by: Soohyoun Ahn, et al.
Published: (2018-01-01)

Clostridium difficile – an Important Opportunistic Pathogen in Healthcare-Associated Infections
by: Soohyoun Ahn, et al.
Published: (2014-09-01)

Clostridium difficile: An Important Opportunistic Pathogen in Healthcare-Associated Infections
by: Soohyoun Ahn, et al.
Published: (2018-01-01)

Clostridium difficile – an Important Opportunistic Pathogen in Healthcare-Associated Infections
by: Soohyoun Ahn, et al.
Published: (2014-09-01)

Antisecretory treatment efficacy by proton pump inhibitors at gastroduodenal ulcer bleedings
by: M. A. Evseyev, et al.
Published: (2010-06-01)

CAG News Page
by: Desmond Leddin, et al.
Published: (2001-01-01)

The effect of Clostridium difficile infection on the course of liver cirrhosis
by: A. A. Driga, et al.
Published: (2018-08-01)

Clostridium difficile Infection Worsens the Prognosis of Ulcerative Colitis
by: María E Negrón, et al.
Published: (2014-01-01)

Acute Appendicitis: An Extracolonic Manifestation of Clostridium difficile Colitis
by: Ali Ridha, et al.
Published: (2017-01-01)

Genotypic Investigation of Clostridium difficile in Prince Edward Island
by: H Martin, et al.
Published: (2008-01-01)

Refractory and relapsing forms of <i>Clostridium difficile</i>-associated colitis
by: A. A. Sheptulin
Published: (2011-03-01)

New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2014-11-01)

Proton Pump Inhibitors and Clopidogrel – Hazardous Drug Interaction or Hazardous Interpretation of Data?
by: Paul Moayyedi, et al.
Published: (2009-01-01)

High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
by: Yu-Hsi Hsieh, et al.
Published: (2013-01-01)